latrepirdine has been researched along with Amentia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, H; Arai, T; Bachurin, SO; Buchman, VL; Goedert, M; Hasegawa, M; Kametani, F; Ninkina, N; Nonaka, T; Yamashita, M | 1 |
| Burns, A; Sachdeva, D | 1 |
| Sano, M | 1 |
1 review(s) available for latrepirdine and Amentia
| Article | Year |
|---|---|
Dimebolin in dementia.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Histamine H1 Antagonists; Humans; Indoles; Nootropic Agents; Randomized Controlled Trials as Topic | 2011 |
2 other study(ies) available for latrepirdine and Amentia
| Article | Year |
|---|---|
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Cell Line; Dementia; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Inclusion Bodies; Indoles; Methylene Blue | 2009 |
ICAD 2010: Detection may hold the key to treatment. International Conference on Alzheimer Disease (ICAD) 2010 Honolulu, HI, USA, 10–15 July 2010.
Topics: Alzheimer Disease; Dementia; Humans; Indoles | 2010 |